Smart-Money SignalNeutral · 52/100— Insiders are net buyers over 90 days ($128K, 19 buys vs 0 sales)
Revenue$33.7M
Net Income$39.2M
EPS$1.02
Market Cap$125.2M
Price Performance
Historical data including institutional events
Company Profile
G
Garo H. Armen
CEO & Executive Director
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
